Physostigmine-methiodide
General
Type : Derivative of physostigmine-eserine,Natural_modified,Carbamate,Indole
Chemical_Nomenclature : Pyrrolo(2,3-b)indolium, 1,2,3,3a,8,8a-hexahydro-1,1,3a,8(or 1,3a,8,8)-tetramethyl-5-(((methylamino)carbonyl)oxy)-, iodide, (3aS-cis)-
Canonical SMILES : CC12CCN(C1[N+](C3=C2C=C(C=C3)OC(=O)NC)(C)C)C.[I-]
InChI : InChI=1S\/C16H23N3O2.HI\/c1-16-8-9-18(3)14(16)19(4,5)13-7-6-11(10-12(13)16)21-15(20)17-2\;\/h6-7,10,14H,8-9H2,1-5H3\;1H\/t14-,16+\;\/m1.\/s1
InChIKey : SLSBBKOEHGUBBZ-XMZRARIVSA-N
Other name(s) : AR-45,6091-11-8
MW : 417.285
Formula : C16H24IN3O2
CAS_number :
PubChem : 111148
UniChem : SLSBBKOEHGUBBZ-XMZRARIVSA-N
IUPHAR :
Wikipedia :
Target
References (1)
| Title : The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex - Shaw_1985_Mol.Pharmacol_28_527 |
| Author(s) : Shaw KP , Aracava Y , Akaike A , Daly JW , Rickett DL , Albuquerque EX |
| Ref : Molecular Pharmacology , 28 :527 , 1985 |
| Abstract : Shaw_1985_Mol.Pharmacol_28_527 |
| ESTHER : Shaw_1985_Mol.Pharmacol_28_527 |
| PubMedSearch : Shaw_1985_Mol.Pharmacol_28_527 |
| PubMedID: 2417099 |